Evidence map›Paper›PMID 30884906›Full record

ReviewMicroorganisms2019

The Production and Delivery of Probiotics: A Review of a Practical Approach.

Kurt Fenster, Barbara Freeburg, Chris Hollard, Connie Wong, Rune Rønhave Laursen, Arthur C Ouwehand

Abstract readReview
In one paragraph

Review in Microorganisms, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 138 papers.

0numbers the graph read from it
0cells of the map it votes in
138citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

138 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Marine-DerivedInternational journal of molecular sciences · 2026
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

78 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kurt FensterDuPont Nutrition and Health, Madison, WI 53716, USA. kurt.fenster@dupont.com.
Barbara FreeburgDuPont Nutrition and Health, Madison, WI 53716, USA. barbara.freeburg@dupont.com.
Chris HollardDuPont Nutrition and Health, Madison, WI 53716, USA. chris.hollard@dupont.com.
Connie WongDuPont Nutrition and Health, Madison, WI 53716, USA. Connie.wong@dupont.com.
Rune Rønhave LaursenDuPont Nutrition Biosciences ApS, 8220 Brabrand, Denmark. runerl@gmail.com.
Arthur C OuwehandDuPont Nutrition and Health, 02460 Kantvik, Finland. arthur.ouwehand@dupont.com.ORCID 0000-0001-8348-0633

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To successfully deliver probiotic benefits to the consumer, several criteria must be met. Here, we discuss the often-forgotten challenges in manufacturing the strains and incorporating them in consumer products that provide the required dose at the end of shelf life. For manufacturing, an intricate production process is required that ensures both high yield and stability and must also be able to meet requirements such as the absence of specific allergens, which precludes some obvious culture media ingredients. Reproducibility is important to ensure constant high performance and quality. To ensure this, quality control throughout the whole production process, from raw materials to the final product, is essential, as is the documentation of this quality control. Consumer product formulation requires extensive skill and experience. Traditionally, probiotic lactic acid bacteria and bifidobacteria have been incorporated in fermented dairy products, with limited shelf life and refrigerated storage. Currently, probiotics may be incorporated in dietary supplements and other "dry" food matrices which are expected to have up to 24 months of stability at ambient temperature and humidity. With the right choice of production process, product formulation, and strains, high-quality probiotics can be successfully included in a wide variety of delivery formats to suit consumer requirements.

Indexed as

BifidobacteriumLactobacillusmanufacturingprobioticsstrain stability

Identifiers

PMID30884906
PMCPMC6463069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.